According to MarkNtel Advisors, the Global Flow Cytometry in Oncology Market size is expecting around 11.2% CAGR during 2021-26. Flow Cytometry has gained immense popularity worldwide owing to its clinical utility, especially for hematological malignancies & therapeutic monitoring. Swift advancements in flow cytometry technology are surging its adoption across numerous diagnostics centers & clinical research laboratories.

Moreover, the burgeoning research activities on immuno-oncology, coupled with an increasing number of cancer patients, are also fueling the growth of the Global Flow Cytometry in Oncology Market. However, the lack of skilled professionals and the high costs of the product are the prominent factors that might restrain the market growth in the coming years, further states the research report, “Global Flow Cytometry in Oncology Market Analysis, 2021.”

“In case you missed it, we are currently revising our reports. Click on the below to get the most latest research data with forecasts for years 2024 to 2030, including market size, industry trends, and competitive analysis. It wouldn't take long for the team to deliver the most recent version of the report.”

Download Sample PDF Copy of this Report: - https://www.marknteladvisors.com/query/request-sample/flow-cytometry-in-oncology-market.html

Flow Cytometry in Oncology Market Segmentation Highlight:

  • By Type (Assay & Kits, Instruments, Reagents & Consumables, Software)
  • By Technology (Cell Based, Bead Based)
  • By Type of Cancer (Hematological Malignancies (Lymphoma, Leukemia, Myeloma), Solid Tumors (Breast Cancer, Prostate Cancer, Colorectal Cancer, Lung Cancer))
  • By Application (Translational Research, Clinical Applications (Screening & Diagnostics, Treatment Monitoring))
  • By End User (Diagnostic Laboratories, Hospitals & Healthcare Centers, Academic & Research Institutes)
  • By Region (North America, South America, Europe, Middle East & Africa, Asia-Pacific)
  • By Country (The US, Canada, Mexico, Brazil, The UK, Germany, France, Italy, Spain, UAE, Saudi Arabia, South Africa, India, China, Japan, South Korea)

Cell-Based Flow Cytometry to Contribute Significantly to the Market Growth through 2026

In 2020, Cell-Based flow cytometry acquired more than 80% share of the global market. Cell membranes are light-permeable, and the cell-based flow cytometry technology exploits this property to provide clinical insights to physicians, particularly in hematological malignancies. This technology is also beneficial in identifying the absolute percentage of cells present in a sample. It is also utilized for immunophenotypic detection of Minimal Residual Disease (MRD) in Adult Acute Lymphoblastic Leukemia (ALL).

Further, the clinical application of cell-based flow cytometry in the screening & diagnosis of hematological malignancies and the increasing use of targeted drugs in the treatment of hematological malignancies are other crucial aspects augmenting the overall market growth.

With Rising Cases of Hematological Malignancies, North America Acquired the Largest Market Share

With the extensive presence of leading market players & their focus on expanding their product portfolio to offer advanced solutions for cancer diagnosis & screening, North America dominates the flow cytometry in oncology market. Further, various ongoing technological innovations to advance & enhance the overall scope of precision oncology are also augmenting the regional market growth.

In addition, the growing incidence of solid tumors & hematological malignancies, the rising geriatric population, and favorable reimbursement policies across the region are other crucial aspects expected to bolster the North America Market in the coming years.

Explore the Full Report with Charts, Table of Contents, and List of Figures – https://www.marknteladvisors.com/research-library/flow-cytometry-in-oncology-market.html

Competitive Landscape

According to MarkNtel Advisors, the leading players in the  Flow Cytometry in Oncology Market are Agilent Technologies, Inc., Apogee Flow Systems Ltd., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Cytognos, S.L., Danaher Corporation, Luminex Corporation, Sony Corporation, and Cytek Biosciences.

Key Questions Answered in the Research Report

  1. What are the current & future trends in the Flow Cytometry in Oncology Market?
  2. How has the industry been evolving in terms of geography & service adoption?
  3. How has the competition been shaping across the globe, followed by their comparative factorial indexing?
  4. What are the key growth drivers & challenges for the Flow Cytometry in Oncology Market?
  5. What are the customer orientation, purchase behavior, and expectations from the flow cytometry in oncology providers across the globe?

Who We Are:

Our team entails professional analysts and researchers who intelligently utilize research techniques to procure detail-driven, unbiased, and reliable data encompassing the industry. We aim to nurture a result-oriented team to offer strategically-moving insights to our clients. 

Our fact-based reports allow the user to design their motives, funds, and strategies, with a higher focus on mitigating confusion and bringing forward a clear insight into the industry. It further allows the clients to identify the lucrative opportunities awaiting.

Insights offered by MarkNtel Advisors comprise in-depth information on regional & country-based trends emerging in the industry. The team studies & compiles the prospects, ensuring consistency in reports.

Our services are beyond offering research reports to the clients and further expand into addressing queries while incorporating with them for advice, development, & execution of strategies for exception growth.

Other Trending Reports:

For Media Inquiries, Please Contact: 

Call: +1 628 895 8081 | +91 120 4278433

Email: [email protected]

Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511 

Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India